Featured Editorial
-
Sourcing Through The Tariff Mess: What 2026 Actually Means For Clinical Supply
11/6/2026
US tariff changes are reshaping clinical supply sourcing. Learn how pharmaceutical duties, country-of-origin documentation and temporary import provisions affect trial materials.
-
The Handoff Problem: Where Clinical Supply Execution Actually Breaks
11/5/2026
Clinical supply handoffs can delay patient dosing despite adequate inventory. Learn how cross-functional planning, deployable inventory, and risk-based decisions improve trial execution.
-
Beyond The Checklist: Auditing Clinical Supply Export Compliance
11/4/2026
Auditing clinical supply export compliance means testing shipment controls, restricted party screening, technology transfers, and partner oversight to prevent risks and delays.
-
How A Comparator Is Really Bought
11/3/2026
Comparator sourcing decisions affect clinical trial budgets, documentation, shelf life, and supply continuity. Learn how market constraints can change comparator supply plans.
-
Clinical Trial Supplies: A Fast-Growing Market Built On Logistics
11/2/2026
Clinical trial supplies market growth is driving changes in logistics, forecasting, outsourcing, and distribution. Explore the operational decisions shaping clinical supply.
-
Why Clinical Supply Needs Creativity
10/29/2026
Clinical supply teams need creative strategies for packaging, labeling, depot distribution and IRT resupply to adapt to changing enrollment, timelines and country requirements.
-
The Operational Challenge Of Concurrent Shelf Life Extensions
10/28/2026
Concurrent shelf life extensions can complicate global clinical trial supply, creating different expiry dates, labeling requirements, inventory constraints and country activation risks.
-
An Incomplete Response: Will The FDA Finish What It Started With Real-Time CRLs?
10/28/2026
FDA’s real-time CRL releases face legal and operational hurdles. Could AI-assisted redaction make transparency faster and more consistent?
-
Clinical Trial Supply Challenges In Alzheimer's Trials
10/27/2026
Alzheimer’s trials challenge clinical supply teams with volatile enrollment, global distribution, cold chain needs, real-time forecasting and patient-centered planning.
-
Policy Is Redefining Clinical Trials. Clinical Supply Must Respond.
10/23/2026
Clinical trial policy is shifting research closer to patients, creating new demands for forecasting, distribution, inventory, accountability, cold chain, and cross-functional planning.